Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1997 3
2000 2
2001 1
2002 1
2003 2
2005 2
2008 2
2009 4
2010 1
2011 1
2012 2
2013 1
2016 1
2018 1
2019 1
2020 2
2022 4
2023 5
2024 4
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias-A report from the European Society of Cardiology Cardiovascular Round Table.
Mach F, Visseren FLJ, Cater NB, Salhi N, Soronen J, Ray KK, Delgado V, Jukema JW, Laufs U, Zamorano JL, Ros E, Plat J, Gesztes AG, Tokgozoglu L, Packard C, Libby P. Mach F, et al. Among authors: cater nb. J Clin Lipidol. 2024 Sep-Oct;18(5):e685-e700. doi: 10.1016/j.jacl.2024.07.001. Epub 2024 Jul 6. J Clin Lipidol. 2024. PMID: 39289123 Review.
Effects of ertugliflozin on uric acid and gout-related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV.
Sridhar VS, Cosentino F, Dagogo-Jack S, McGuire DK, Pratley RE, Cater NB, Noyes Essex M, Mancuso JP, Zhao Y, Cherney DZI. Sridhar VS, et al. Among authors: cater nb. Diabetes Obes Metab. 2024 Nov;26(11):5336-5346. doi: 10.1111/dom.15895. Epub 2024 Sep 2. Diabetes Obes Metab. 2024. PMID: 39219437 Clinical Trial.
Long-term weight loss and cardiorenal outcomes by baseline BMI in the VERTIS CV trial.
Cosentino F, Dagogo-Jack S, Frederich R, Cannon CP, Cherney DZI, Mancuso JP, Wynant W, Xing A, Gantz I, Cater NB, Pratley RE. Cosentino F, et al. Among authors: cater nb. Diabetes Obes Metab. 2025 Feb;27(2):583-594. doi: 10.1111/dom.16050. Epub 2024 Dec 18. Diabetes Obes Metab. 2025. PMID: 39696829 Free PMC article. Clinical Trial.
Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial.
Pandey A, Kolkailah AA, McGuire DK, Frederich RC, Cater NB, Cosentino F, Pratley RE, Dagogo-Jack S, Cherney DZI, Wynant W, Gantz I, Mancuso JP, Masiukiewicz U, Cannon CP. Pandey A, et al. Among authors: cater nb. Eur J Heart Fail. 2025 Mar;27(3):521-526. doi: 10.1002/ejhf.3511. Epub 2025 Jan 10. Eur J Heart Fail. 2025. PMID: 39792342 Free PMC article. Clinical Trial.
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.
Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, Kaab S, Schotten U, Wegscheider K, Boriani G, Brandes A, Ezekowitz M, Diener H, Haegeli L, Heidbuchel H, Lane D, Mont L, Willems S, Dorian P, Aunes-Jansson M, Blomstrom-Lundqvist C, Borentain M, Breitenstein S, Brueckmann M, Cater N, Clemens A, Dobrev D, Dubner S, Edvardsson NG, Friberg L, Goette A, Gulizia M, Hatala R, Horwood J, Szumowski L, Kappenberger L, Kautzner J, Leute A, Lobban T, Meyer R, Millerhagen J, Morgan J, Muenzel F, Nabauer M, Baertels C, Oeff M, Paar D, Polifka J, Ravens U, Rosin L, Stegink W, Steinbeck G, Vardas P, Vincent A, Walter M, Breithardt G, Camm AJ. Kirchhof P, et al. Among authors: cater n. Europace. 2012 Jan;14(1):8-27. doi: 10.1093/europace/eur241. Epub 2011 Jul 26. Europace. 2012. PMID: 21791573 Free PMC article. Review.
Cardiovascular and Renal Outcomes with Ertugliflozin by Baseline Use of Renin-Angiotensin-Aldosterone System Inhibitors or Diuretics, Including Mineralocorticoid Receptor Antagonist: Analyses from the VERTIS CV Trial.
Cherney DZI, Frederich R, Pratley RE, Cosentino F, Dagogo-Jack S, Pong A, Gantz I, Cater NB, Mancuso JP, Masiukiewicz U, Cannon CP. Cherney DZI, et al. Among authors: cater nb. Kidney Dis (Basel). 2025 Feb 4;11(1):63-74. doi: 10.1159/000543162. eCollection 2025 Jan-Dec. Kidney Dis (Basel). 2025. PMID: 40028005 Free PMC article.
Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial.
Cosentino F, Cannon CP, Frederich R, Cherney DZI, Dagogo-Jack S, Pratley RE, Mancuso JP, Maldonado M, Cater NB, Wang S, McGuire DK. Cosentino F, et al. Among authors: cater nb. Circulation. 2022 Aug 23;146(8):652-654. doi: 10.1161/CIRCULATIONAHA.121.058294. Epub 2022 Aug 22. Circulation. 2022. PMID: 35994565 Free PMC article. Clinical Trial. No abstract available.
Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group.
Rao SV, Eikelboom J, Steg PG, Lincoff AM, Weintraub WS, Bassand JP, Rao AK, Gibson CM, Petersen JL, Mehran R, Manoukian SV, Charnigo R, Lee KL, Moscucci M, Harrington RA; Academic Bleeding Consensus Multidisciplinary Working Group. Rao SV, et al. Am Heart J. 2009 Dec;158(6):881-886.e1. doi: 10.1016/j.ahj.2009.10.008. Am Heart J. 2009. PMID: 19958852
Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease.
Kim JM, Bhatt DL, Dagogo-Jack S, Cherney DZI, Cosentino F, McGuire DK, Pratley RE, Liu CC, Cater NB, Frederich R, Mancuso JP, Cannon CP. Kim JM, et al. Among authors: cater nb. Diabetes Obes Metab. 2023 May;25(5):1398-1402. doi: 10.1111/dom.14965. Epub 2023 Feb 14. Diabetes Obes Metab. 2023. PMID: 36594154 No abstract available.
39 results